Cantor Fitzgerald reiterated a Neutral rating and $75.00 price target on National Health Investors (NYSE: NHI) after adjusting estimates. Cantor ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst EPS Change

NHI Announces Promotion of Kevin Pascoe to Chief Investment OfficerFebruary 21, 2017 6:00 AM National Health Investors (NHI) Reports Q4 Normalized FFO of $1.27February 17, 2017 6:00 AM National Health Investors (NHI) Raises Quarterly Dividend 5.6% to $0.95; 5.1% YieldFebruary 17, 2017 5:47 AM NHI Announces Increase in First Quarter 2017 DividendFebruary 17, 2017 5:45 AM NHI Announces Fourth Quarter 2016 ResultsFebruary 17, 2017 5:30 AM